Ceftriaxone: Difference between revisions
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
'''| [[Ceftriaxone indications and usage|Indications and Usage]]''' | '''| [[Ceftriaxone indications and usage|Indications and Usage]]''' | ||
'''| [[Ceftriaxone contraindications|Contraindications]]''' | '''| [[Ceftriaxone contraindications|Contraindications]]''' | ||
'''| [[Ceftriaxone warnings|Warnings | '''| [[Ceftriaxone warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Ceftriaxone adverse reactions|Adverse Reactions]]''' | '''| [[Ceftriaxone adverse reactions|Adverse Reactions]]''' | ||
'''| [[Ceftriaxone overdosage|Overdosage]]''' | '''| [[Ceftriaxone overdosage|Overdosage]]''' | ||
'''| [[Ceftriaxone clinical studies|Clinical Studies]]''' | '''| [[Ceftriaxone clinical studies|Clinical Studies]]''' | ||
'''| [[Ceftriaxone dosage and administration|Dosage and Administration]]''' | '''| [[Ceftriaxone dosage and administration|Dosage and Administration]]''' | ||
'''| [[Ceftriaxone compatibility | '''| [[Ceftriaxone compatibility and stability|Compatibility and Stability]]''' | ||
'''| [[Ceftriaxone directions for use|Directions For Use]]''' | '''| [[Ceftriaxone directions for use|Directions For Use]]''' | ||
'''| [[Ceftriaxone how supplied|How Supplied]]''' | '''| [[Ceftriaxone how supplied|How Supplied]]''' | ||
Revision as of 18:23, 31 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Overview
Ceftriaxone (INN) (IPA: Template:IPA) is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram positive and Gram negative bacteria. In most cases, it is considered to be equivalent to cefotaxime in terms of safety and efficacy. Ceftriaxone sodium is marketed by Hoffman-La Roche under the trade name Rocephin.
Category
Cephalosporins,third generation.
US Brand Names
CEFTRIAXONE® ,ROCEPHIN®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility and Stability | Directions For Use | How Supplied | Labels and Packages
References
http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/050796lbl.pdf